Home > Publications > Medical Specialty > Internal Medicine > Haematology > Haematology > Blood 2025 Conference Review
Blood 2025 Conference Review

Blood 2025 Conference Review

In this edition:

GoldiLox: pirtobrutinib + glofitamab in mantle cell lymphoma with prior BTKi exposure
Trial eligibility of real-world Australian R/R DLBCL patients
Romosozumab in multiple myeloma with skeletal events & prior bisphosphonates
Chemotherapy-free treatment in Ph-positive ALL
Treatment changes for adult Ph-negative ALL
Adverse impacts of measurable cyclophosphamide on day 0 of allo-SCT
EMBRACE: a multidisciplinary model of care for inherited bone marrow failure syndromes
Remote patient monitoring after CART-cell therapy
Cold-stored platelets in bleeding patients undergoing cardiothoracic surgery
Red cell transfusions in pregnant/post-partum women in Northern Territory
Risk factors for clonal haematopoiesis of indeterminate potential (CHIP)
COBRRA: bleeding risk with rivaroxaban vs. apixaban in acute venous thromboembolism

You need to be logged in to access this content.

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.